A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
出版年份 2021 全文链接
标题
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-02
DOI
10.3389/fcimb.2021.637313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Construction and characterization of a chimeric lysin ClyV with improved bactericidal activity against Streptococcus agalactiae in vitro and in vivo
- (2020) Li Huang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
- (2020) Shukho Kim et al. Journal of Global Antimicrobial Resistance
- Application of Adaptive Evolution to Improve the Stability of Bacteriophages during Storage
- (2020) Kelvin K. Kering et al. Viruses-Basel
- The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity
- (2020) Yuyu Yuan et al. Microbial Biotechnology
- LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity
- (2020) Shukho Kim et al. Viruses-Basel
- Linker editing of pneumococcal lysin ClyJ conveys improved bactericidal activity
- (2019) Hang Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Endolysins as emerging alternative therapeutic agent to counter drug resistant infections.
- (2019) Vijay Singh Gondil et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiofilm potential of Seabuckthorn silver nanoparticles (SBT@AgNPs) against Pseudomonas aeruginosa
- (2019) Vijay Singh Gondil et al. 3 Biotech
- MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms
- (2018) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection
- (2018) Nak-Hyun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
- (2017) Mingquan Guo et al. Frontiers in Microbiology
- Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
- (2016) Hugo Oliveira et al. Frontiers in Microbiology
- ‘Artilysation’ of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci
- (2016) Lorena Rodríguez-Rubio et al. Scientific Reports
- Novel Phage Lysin Capable of Killing the Multidrug-Resistant Gram-Negative Bacterium Acinetobacter baumannii in a Mouse Bacteremia Model
- (2015) Rolf Lood et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii : Mechanisms and epidemiology
- (2015) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa
- (2015) Hang Yang et al. Frontiers in Microbiology
- A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method
- (2015) Hang Yang et al. Scientific Reports
- Engineered Endolysin-Based "Artilysins" To Combat Multidrug-Resistant Gram-Negative Pathogens
- (2014) Y. Briers et al. mBio
- Engineered bacteriophage lysins as novel anti-infectives
- (2014) Hang Yang et al. Frontiers in Microbiology
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- The Future of Antibiotics and Resistance
- (2013) Brad Spellberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bacteriophage endolysins as novel antimicrobials
- (2012) Mathias Schmelcher et al. Future Microbiology
- Characterization of Modular Bacteriophage Endolysins from Myoviridae Phages OBP, 201φ2-1 and PVP-SE1
- (2012) Maarten Walmagh et al. PLoS One
- Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria
- (2011) Meng-Jiun Lai et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa
- (2011) Y. Briers et al. JOURNAL OF APPLIED MICROBIOLOGY
- Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens
- (2010) Vincent A. Fischetti INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144
- (2009) Yves Briers et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nosocomial Outbreak of Infection With Pan–Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital
- (2009) Raquel Valencia et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Bacteriophage lysins as effective antibacterials
- (2008) Vincent A Fischetti CURRENT OPINION IN MICROBIOLOGY
- Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
- (2008) Ian Chopra et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now